Thomas D. Schmittgen

Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.

Inhibition of pre-mRNA splicing by cisplatin and platinum analogs.

Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.

A high-throughput method to monitor the expression of microRNA precursors.

Diverse gene expression pattern during 5-fluorouridine-induced apoptosis.

Increased expression of microRNA-155 in Epstein-Barr virus transformed lymphoblastoid cell lines.

Real-time expression profiling of microRNA precursors in human cancer cell lines.

MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts.

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.

Apoptosis induced by novel aldehyde calpain inhibitors in human tumor cell lines.

Comparison of RNA assay methods used to normalize cDNA for quantitative real-time PCR.

Expression profiling identifies microRNA signature in pancreatic cancer.

Dynamin 2 regulates riboflavin endocytosis in human placental trophoblasts.

The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding.

Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas.

Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors.

Computational analysis of biological functions and pathways collectively targeted by co-expressed microRNAs in cancer.

MicroRNAs and cancer: profile, profile, profile.

Part B--microRNAs: microRNA methods.

Real-time PCR quantification of precursor and mature microRNA.

MicroRNAs modulate the chemosensitivity of tumor cells.

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Benign metastasizing leiomyoma of the lung: clinicopathologic, immunohistochemical, and micro-RNA analyses.

Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts.

Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia.

Analyzing real-time PCR data by the comparative C(T) method.

Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis.

High-throughput real-time PCR.

Regulation of microRNA processing in development, differentiation and cancer.

Integrating the MicroRNome into the study of lung disease.

Detection of microRNA expression in human peripheral blood microvesicles.

A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets.

Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.

Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.

miR-31: a master regulator of metastasis?

Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection.

MicroRNAs are mediators of androgen action in prostate and muscle.

miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines.

miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.

MicroRNA replacement therapy for cancer.

miR-221 silencing blocks hepatocellular carcinoma and promotes survival.

Microbiomarkers with big impact in CLL.

A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.

Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation.

Studies on the Antileishmanial Mechanism of Action of the Arylimidamide DB766: Azole Interactions and Role of CYP5122A1.